It costs nothing for an organisation to issue vague statements in favour of transparency and integrity. This time, a World Health Organization joint statement on clinical trials transparency, signed by 15 major non-industry research funders (see box), gives unusual grounds for optimism. Where previous documents have been shapeless, this one makes clear commitments to transparency, with timelines; it promises unambiguous outcomes where compliance can be easily assessed; it gives technical details around implementation; and crucially it includes a commitment for open self-auditing, so progress can be monitored.
The WHO joint statement from funders on trials transparency
19 June 2017
Goldacre, B. (2017). The WHO joint statement from funders on trials transparency. BMJ, j2816. https://doi.org/10.1136/bmj.j2816